The Home Diagnostics TRUE Family of Products Make Diabetes Testing More Affordable

American Association of Diabetes Educators (AADE) 36th Annual Meeting, Booth #126 - Home Diagnostics, Inc. (NASDAQ:HDIX), a leading manufacturer and marketer of diabetes testing supplies, is making diabetes testing more affordable with its low cost TRUE family of products. As people continue to struggle to make ends meet, diabetes patients also face the recurring cost of testing supplies, including test strips and meters. As store branded glucose monitoring systems, the TRUE family of products from Home Diagnostics costs significantly less than the national brands.

According to a CNN poll, one in three respondents said they had cut back on necessities such as food or medicine because of the economy. To provide affordable diabetes care products without sacrificing quality, retailers, including CVS, Rite Aid and Walgreens, partner with Home Diagnostics for their store branded diabetes testing supplies. Blood glucose monitoring products manufactured by Home Diagnostics can typically save people with diabetes up to $400 per year on diabetes supplies* in comparison to competitive products and are covered by Medicare, Medicaid and most third-party insurance providers.

Home Diagnostics’ diabetes testing supplies, including the world’s smallest blood glucose meter, TRUE2go™, offers state-of-the-art technology at an affordable price. About the size of a quarter and small enough to fit in a pocket or purse, TRUE2go attaches to the top of a vial of test strips and offers patients the convenience of on-the-go testing to help them better manage their diabetes. TRUE2go also features no-coding technology and a small sample size that make it more convenient for diabetics to test their blood glucose levels more often, allowing for greater control of their glucose levels.

The meter is compatible with Home Diagnostics’ new TRUEtest™ test strips featuring the company’s patent-pending, state-of-the-art GoldSensor™ laser accuracy and TRUEfill™ beveled tip. These advanced features ensure highly accurate test results and first test success by allowing for greater sampling precision and consistency.

“The availability and affordability of high quality blood glucose monitoring supplies is crucial for diabetes patients. Unfortunately, the cost of diabetes testing supplies, combined with the financial strains of a recession, can force some patients to sacrifice their well-being by testing less frequently,” said Joe Capper, president and CEO of Home Diagnostics. “At Home Diagnostics, we develop high quality, state-of-the-art products like TRUE2go that are comparable to name brands. Our products offer patients the best of both worlds — tremendous value without the need to sacrifice quality of care.”

*Data on file with Home Diagnostics, Inc.

About Home Diagnostics, Inc.

Based in Fort Lauderdale, Florida, Home Diagnostics, Inc. (NASDAQ:HDIX) is a leading developer, manufacturer and marketer of diabetes management products. Home Diagnostics, Inc. offers a portfolio of high-quality blood glucose monitoring systems that spans the spectrum of features and benefits to help every person with diabetes better monitor and manage their disease. The Home Diagnostics, Inc. product line includes TRUE2go™, TRUEresult™, TRUEbalance™, TRUEtrack®, Sidekick®, TRUEread™ and Prestige Smart System® blood glucose monitoring systems. The products are available in more than 45,000 pharmacies throughout the U.S. Home Diagnostics is the exclusive co-brand supplier of blood glucose monitoring supplies for leading pharmacies including CVS, Rite Aid and Walgreens, as well as distributors such as AmerisourceBergen, Cardinal Health, McKesson, Invacare and Liberty Medical. Home Diagnostics, Inc. was named one of Forbes magazine’s “200 Best Small Companies” in 2008, and in 2009 received several recognitions for the company’s TRUE2go blood glucose meter, including a Medical Design Excellence Award (MDEA) and a Gold Award in the Medical/Test Equipment category as part of appliance DESIGN Magazine’s 22nd Annual Excellence in Design (EID) Awards Competition. For more information please visit www.homediagnostics.com.

Forward-Looking Statements

The above statements include forward-looking statements and are subject to risks and uncertainties. Forward-looking statements give the Company’s current expectations and projections relating to its financial condition, results of operations, plans, objectives, future performance and business. The statements can be identified by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events.

All statements other than statements of historical facts included in this release that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements.

These forward-looking statements are largely based on our expectations and beliefs concerning future events, which reflect estimates and assumptions made by the Company’s management. These estimates and assumptions reflect the Company’s best judgment based on currently known market conditions and other factors relating to the Company’s operations and business environment, all of which are difficult to predict and many of which are beyond its control.

Although the Company believes its estimates and assumptions to be reasonable, they are inherently uncertain and involve a number of risks and uncertainties that are beyond the Company’s control. In addition, management’s assumptions about future events may prove to be inaccurate. Management cautions all readers that the forward-looking statements contained in this release are not guarantees of future performance, and the Company cannot assure any reader that those statements will be realized or the forward-looking events and circumstances will occur. Actual results may differ materially from those anticipated or implied in the forward-looking statements due to the factors listed in the “Risk factors” and “Management’s discussion and analysis of financial condition and results of operations” sections contained in its filings with the Securities and Exchange Commission. All forward-looking statements speak only as of the date of this release. The Company does not intend to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise, except as required by law. These cautionary statements qualify all forward-looking statements attributable to the Company or persons acting on its behalf.

TRUE2go, TRUEresult, TRUEtest, TRUEbalance, TRUEtrack, Sidekick, TRUEread, Prestige Smart System, GoldSensor and TRUEfill are trademarks of Home Diagnostics, Inc. All other trademarks are property of their respective owners.

Home Diagnostics (MM) (NASDAQ:HDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024